Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow-up in Women with a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008-R-02, 20677 [E8-8105]

Download as PDF 20677 Federal Register / Vol. 73, No. 74 / Wednesday, April 16, 2008 / Notices EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN—Continued Number of respondents Form name Total burden hours Average hourly wage rate* Total cost burden Organizational leader questionnaire ................................................................ 75 38 $38.20 $1,451.60 Total .......................................................................................................... 375 188 NA $6,278.60 *Based upon the mean of the average wages for health professionals for the training participant questionnaire and for executives, administrators, and managers for the organizational leader questionnaire presented in the National Compensation Survey: Occupational Wages in the United States, June 2005, U.S. Department of Labor, Bureau of Labor Statistics. Estimated Annual Costs to the Federal Government DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES The total cost to the government for this activity is estimated to be $127,442 to conduct the two one-time questionnaires and to analyze and present its results. This amount includes costs for developing the data collection tools ($50,976); collecting the data ($25,488); analyzing the data and reporting the findings ($44,605); and administrative support activities ($6,373). Centers for Disease Control and Prevention Centers for Disease Control and Prevention Advisory Committee on Immunization Practices: Notice of Charter Renewal Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow-up in Women with a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008–R–02 Request for Comments In accordance with the above-cited Paperwork Reduction Act legislation, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research, quality improvement and information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. jlentini on PROD1PC65 with NOTICES Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through April 1, 2010. For information, contact Larry Pickering, M.D., Executive Secretary, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E05, Atlanta, Georgia 30333, telephone 404/639–8767 or fax 404/639–8626. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8135 Filed 4–15–08; 8:45 am] BILLING CODE 4163–18–P In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–3 p.m., May 28, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Improving Postpartum Followup in Women with a Gestational DiabetesAffected Pregnancy, PEP 2008–R–02.’’ For Further Information Contact: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–8105 Filed 4–15–08; 8:45 am] Dated: April 8, 2008. Carolyn M. Clancy, Director. [FR Doc. E8–8060 Filed 4–15–08; 8:45 am] BILLING CODE 4160–90–M BILLING CODE 4163–18–P VerDate Aug<31>2005 19:08 Apr 15, 2008 Jkt 214001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 73, Number 74 (Wednesday, April 16, 2008)]
[Notices]
[Page 20677]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8105]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Improving Postpartum Follow-up in Women with a 
Gestational Diabetes-Affected Pregnancy, Potential Extramural Project 
(PEP) 2008-R-02

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-3 p.m., May 28, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Improving Postpartum Follow-up in 
Women with a Gestational Diabetes-Affected Pregnancy, PEP 2008-R-
02.''
    For Further Information Contact: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-8105 Filed 4-15-08; 8:45 am]
BILLING CODE 4163-18-P